Xiaoting Xi
Impact in
- Ophthalmology top 5%
- Retinal Diseases and Treatments
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Inflammasome and immune disorders 3
- Angiogenesis and VEGF in Cancer 2
-
- Retinal Diseases and Treatments 8
- Glaucoma and retinal disorders 2
- Co-authors
- Yanni Yang (4 shared papers)Xu Zha (2 shared papers)Yuanping Zhang (2 shared papers)Minjun Ma (2 shared papers)Xinyu Fan (1 shared paper)Qianbo Chen (11 shared papers)Xueying Zhao (1 shared paper)Mei Yan (1 shared paper)
- Journals
- Experimental Eye Research (2 papers)Biomedicine & Pharmacotherapy (2 papers)Journal of Cellular Biochemistry (1 paper)Molecular Biology Reports (1 paper)Journal of Diabetes Investigation (1 paper)
- Partner nations
- China
In The Last Decade
Xiaoting Xi
13 papers receiving 393 citations
Peers
Comparison fields: 5 of 69
- Ophthalmology 95
- Cancer Research 95
- Clinical Biochemistry 35
- Physiology 22
- Molecular Biology 263
Countries citing papers authored by Xiaoting Xi
This map shows the geographic impact of Xiaoting Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoting Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoting Xi more than expected).
Fields of papers citing papers by Xiaoting Xi
This network shows the impact of papers produced by Xiaoting Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoting Xi. The network helps show where Xiaoting Xi may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoting Xi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 142 | |
| 2 | 2020 | 121 | |
| 3 | 2020 | 27 | |
| 4 | 2019 | 26 | |
| 5 | 2022 | 13 | |
| 6 | 2022 | 11 | |
| 7 | 2015 | 11 | |
| 8 | 2022 | 11 | |
| 9 | 2023 | 10 | |
| 10 | 2024 | 9 | |
| 11 | 2018 | 8 | |
| 12 | 2024 | 7 | |
| 13 | 2024 | 2 | |
| 14 | 2025 | 0 | |
| 15 | 2024 | 0 |
About Xiaoting Xi
Xiaoting Xi is a scholar working on Molecular Biology, Ophthalmology, Epidemiology, Cancer Research and Immunology, having authored 15 papers that have together received 398 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (8 papers), Autophagy in Disease and Therapy (4 papers), Inflammasome and immune disorders (3 papers), Glaucoma and retinal disorders (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Traditional Chinese Medicine Analysis (2 papers), Advanced Glycation End Products research (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Ophthalmology (95 citations), Cancer Research (95 citations), Clinical Biochemistry (35 citations), Physiology (22 citations) and Molecular Biology (263 citations). Xiaoting Xi has collaborated with scholars based in China. Frequent co-authors include Yanni Yang, Xu Zha, Yuanping Zhang, Minjun Ma, Xinyu Fan, Qianbo Chen, Xueying Zhao, Mei Yan, Jia Ma and Yong Zeng. Their work appears in journals such as Experimental Eye Research, Biomedicine & Pharmacotherapy, Journal of Cellular Biochemistry, Molecular Biology Reports and Journal of Diabetes Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.